Grant: Discovery Grants Program - Individual
University of Toronto
$66,000.00
Development of a novel weight bearing bone biomaterial of calcium polyphosphate (CPP) infiltrated with dicalcium phosphate containing a bone anabolic drug.
EF 2022-23
Résumé
Goal: To develop a CPP construct infiltrated with monetite which incorporates in its matrix a bone anabolic conjugate drug and to maximize the mechanical properties of the construct and optimize its rate of degradation and increase the rate of bone ingrowth.Background: There is a strong need for biodegradable load-bearing bone substitutes for filling bone void defects, alveolar ridge augmentation, spinal cages used in association with spinal fusion procedures. Porous bulk calcium polyphosphate (CPP) constructs may satisfy this need as it is biocompatible, osteoconductive and strong. However, CPP constructs dissolve at a rate much slower in the bone environment than bone formation rate. Dicalcium phosphate biomaterials, such as monetite, have been shown to be biocompatible and osteoconductive. They have the ability to resorb in vivo faster enabling the replacement of the graft by new bone. Feasibility: During the tenure of the previous grant, we have reported a 2-step sinter/anneal treatment for forming porous CPP as a biodegradable bone substitute. To increase the degradation rate without loss of strength of the CPP, we started a study to investigate the effect of doping on mechanical properties and degradation rate. In addition, our collaborative group has developed a method to fabricate monetite constructs that incorporates in their cement matrix a novel bone anabolic conjugate of a bisphosphonate (alendronate) and an EP4 receptor agonist known as C3. One of these constructs of monetite has been implanted on rabbit calvarium and has integrated with the bone surface. The preliminary data is very promising and we believe that constructs of CPP infiltrated with monetite containing C3 can be optimized to improve degradation and function.Objectives: The specific objectives of this project would be: (i) Fabrication, modification and characterize CPP constructs; (ii) Modification of CPP constructs by infiltration with monetite loaded with C3 conjugate drug; (iii) Assess the conjugate binding and stability within the constructs; (iv) Assess degradation of the constructs; (v) Show in vivo efficacy of constructs via a bone implantation pilot study.Significance: Suitable biodegradable materials are important for bone applications and their success. Tailoring the properties of the CPP/monetite/C3 constructs would produce materials with desirable mechanical and chemical properties of a resorbable bone implant for load bearing bone replacement biomaterials.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2018-03721
Name nom
Grynpas, Marc
Department département
Materials Science and Engineering - Materials Science and Engineering
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2022
Competition year année de concours
2018
Award amount
66000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1511
Committee name en
Materials and Chemical Engineering
Committee name fr
Génie chimique et des matériaux
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Installment
inst:5;6
Partie
2
Nb partie
6
Application title
Development of a novel weight bearing bone biomaterial of calcium polyphosphate (CPP) infiltrated with dicalcium phosphate containing a bone anabolic drug.
Application summary
Goal: To develop a CPP construct infiltrated with monetite which incorporates in its matrix a bone anabolic conjugate drug and to maximize the mechanical properties of the construct and optimize its rate of degradation and increase the rate of bone ingrowth.Background: There is a strong need for biodegradable load-bearing bone substitutes for filling bone void defects, alveolar ridge augmentation, spinal cages used in association with spinal fusion procedures. Porous bulk calcium polyphosphate (CPP) constructs may satisfy this need as it is biocompatible, osteoconductive and strong. However, CPP constructs dissolve at a rate much slower in the bone environment than bone formation rate. Dicalcium phosphate biomaterials, such as monetite, have been shown to be biocompatible and osteoconductive. They have the ability to resorb in vivo faster enabling the replacement of the graft by new bone. Feasibility: During the tenure of the previous grant, we have reported a 2-step sinter/anneal treatment for forming porous CPP as a biodegradable bone substitute. To increase the degradation rate without loss of strength of the CPP, we started a study to investigate the effect of doping on mechanical properties and degradation rate. In addition, our collaborative group has developed a method to fabricate monetite constructs that incorporates in their cement matrix a novel bone anabolic conjugate of a bisphosphonate (alendronate) and an EP4 receptor agonist known as C3. One of these constructs of monetite has been implanted on rabbit calvarium and has integrated with the bone surface. The preliminary data is very promising and we believe that constructs of CPP infiltrated with monetite containing C3 can be optimized to improve degradation and function.Objectives: The specific objectives of this project would be: (i) Fabrication, modification and characterize CPP constructs; (ii) Modification of CPP constructs by infiltration with monetite loaded with C3 conjugate drug; (iii) Assess the conjugate binding and stability within the constructs; (iv) Assess degradation of the constructs; (v) Show in vivo efficacy of constructs via a bone implantation pilot study.Significance: Suitable biodegradable materials are important for bone applications and their success. Tailoring the properties of the CPP/monetite/C3 constructs would produce materials with desirable mechanical and chemical properties of a resorbable bone implant for load bearing bone replacement biomaterials.